- Home
- KROS vs EE Comparison
KROS vs EE Comparison
Compare KROS & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | EE |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 902.1M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | KROS | EE |
|---|---|---|
| Price | $20.40 | $27.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $22.20 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 711.3K | 279.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 51.11 |
| EPS | ★ 1.57 | 1.42 |
| Revenue | $246,718,000.00 | ★ $1,185,262,000.00 |
| Revenue This Year | $6,924.79 | $40.00 |
| Revenue Next Year | N/A | $27.68 |
| P/E Ratio | ★ $12.93 | $19.75 |
| Revenue Growth | ★ 37798.31 | 45.09 |
| 52 Week Low | $9.12 | $21.29 |
| 52 Week High | $22.55 | $32.99 |
Technical Indicators
Market Signals| Indicator | KROS | EE |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 55.17 |
| Support Level | $19.76 | $27.48 |
| Resistance Level | $21.76 | $28.58 |
| Average True Range (ATR) | 0.68 | 0.71 |
| MACD | -0.24 | 0.08 |
| Stochastic Oscillator | 28.09 | 77.19 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.